The anti-thymic stromal lymphopoietin antibody (tezepelumab) has therapeutical potential for inadequately controlled asthma. However, evidence comparing tezepelumab with other biologics is scarce. To address this issue, we performed a network meta-analysis to compare and rank the efficacy of five tr...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!